Published in Clin Infect Dis on January 10, 2005
Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59
The genome sequence of Lone Star virus, a highly divergent bunyavirus found in the Amblyomma americanum tick. PLoS One (2013) 1.30
Highly prevalent Coxiella sp. bacterium in the tick vector Amblyomma americanum. Appl Environ Microbiol (2006) 1.17
Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci (2013) 1.00
Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test. Clin Vaccine Immunol (2006) 0.84
Borrelia burgdorferi not confirmed in human-biting Amblyomma americanum ticks from the southeastern United States. J Clin Microbiol (2015) 0.80
TickNET-A Collaborative Public Health Approach to Tickborne Disease Surveillance and Research. Emerg Infect Dis (2015) 0.79
Erythema migrans-like illness among Caribbean islanders. Emerg Infect Dis (2010) 0.79
Distribution of antibodies reactive to Borrelia lonestari and Borrelia burgdorferi in white-tailed deer (Odocoileus virginianus) populations in the eastern United States. Vector Borne Zoonotic Dis (2009) 0.77
Epidemiological study of relapsing fever borreliae detected in Haemaphysalis ticks and wild animals in the western part of Japan. PLoS One (2017) 0.75
Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep (1997) 10.41
Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis (1987) 3.79
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69
Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis (1996) 2.63
Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35
Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol (1992) 2.12
Spirochetes in ticks and antibodies to Borrelia burgdorferi in white-tailed deer from Connecticut, New York State, and North Carolina. J Wildl Dis (1986) 2.04
Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993. J Infect Dis (1995) 1.98
Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis (2001) 1.94
Surveillance for Lyme disease--United States, 1992-1998. MMWR CDC Surveill Summ (2000) 1.91
Solitary erythema migrans in Georgia and South Carolina. Arch Dermatol (1999) 1.91
Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis (2001) 1.84
Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Arch Intern Med (1998) 1.80
Inhibition of efficient polymerase chain reaction amplification of Borrelia burgdorferi DNA in blood-fed ticks. Am J Trop Med Hyg (1997) 1.63
Lyme disease--United States, 2001-2002. MMWR Morb Mortal Wkly Rep (2004) 1.55
Amblyomma americanum: a potential vector of Lyme disease in New Jersey. Science (1984) 1.53
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40
Ticks parasitizing humans in Georgia and South Carolina. J Parasitol (1996) 1.31
Lone star tick-infecting borreliae are most closely related to the agent of bovine borreliosis. J Clin Microbiol (2001) 1.31
A new Borrelia infecting Lone Star ticks. Lancet (1996) 1.24
Evidence of Borrelia lonestari DNA in Amblyomma americanum (Acari: Ixodidae) removed from humans. J Clin Microbiol (2003) 1.18
Evidence supporting the presence of Borrelia burgdorferi in Missouri. Am J Trop Med Hyg (1994) 1.08
Detection of Borrelia lonestari in Amblyomma americanum (Acari: Ixodidae) from Tennessee. J Med Entomol (2003) 1.07
Glycerophosphodiester phosphodiesterase gene (glpQ) of Borrelia lonestari identified as a target for differentiating Borrelia species associated with hard ticks (Acari:Ixodidae). J Clin Microbiol (2004) 1.05
Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites. Arch Dermatol (1998) 1.04
First culture isolation of Borrelia lonestari, putative agent of southern tick-associated rash illness. J Clin Microbiol (2004) 1.01
Attachment sites of four tick species (Acari: Ixodidae) parasitizing humans in Georgia and South Carolina. J Med Entomol (1999) 1.00
Risk of Lyme disease: perceptions of residents of a Lone Star tick-infested community. Bull World Health Organ (2001) 0.96
DNA evidence of Borrelia lonestari in Amblyomma americanum (Acari: Ixodidae) in southeast Missouri. J Med Entomol (2003) 0.96
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 3.96
Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79
Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med (2002) 3.41
Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med (2003) 3.23
Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect Immun (2003) 3.19
Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin Infect Dis (2005) 3.04
Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88
MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67
Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol Microbiol (2007) 2.32
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis (2008) 2.26
Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75
An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med (2002) 1.69
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev (2009) 1.51
Electrical twitch-obtaining intramuscular stimulation in lower back pain: a pilot study. Am J Phys Med Rehabil (2004) 1.49
Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions. Mol Microbiol (2009) 1.45
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis (2012) 1.45
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40
Interaction and transmission of two Borrelia burgdorferi sensu stricto strains in a tick-rodent maintenance system. Appl Environ Microbiol (2004) 1.38
Fitness variation of Borrelia burgdorferi sensu stricto strains in mice. Appl Environ Microbiol (2007) 1.36
Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34
Linear and circular plasmid content in Borrelia burgdorferi clinical isolates. Infect Immun (2003) 1.33
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med (2005) 1.24
Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis (2011) 1.24
Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22
Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis (2010) 1.20
Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol (2009) 1.18
Borrelia burgdorferi gene expression profiling with membrane-based arrays. Methods Enzymol (2002) 1.16
Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol (2008) 1.16
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. J Virol (2012) 1.15
Erythema migrans. Infect Dis Clin North Am (2008) 1.14
Borrelia burgdorferi bba74 is expressed exclusively during tick feeding and is regulated by both arthropod- and mammalian host-specific signals. J Bacteriol (2009) 1.14
Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice. FEMS Microbiol Lett (2004) 1.13
Comparative transcriptional profiling of Borrelia burgdorferi clinical isolates differing in capacities for hematogenous dissemination. Infect Immun (2005) 1.11
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol Infect Dis (2012) 1.10
Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis (2003) 1.08
Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol (2008) 1.08
Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun (2004) 1.08
Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07
Borrelia burgdorferi requires glycerol for maximum fitness during the tick phase of the enzootic cycle. PLoS Pathog (2011) 1.06
Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis (2003) 1.05
Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Clin Infect Dis (2008) 1.03
Real-time PCR for simultaneous detection and quantification of Borrelia burgdorferi in field-collected Ixodes scapularis ticks from the Northeastern United States. Appl Environ Microbiol (2003) 1.02
Identification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733): additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferi. FEMS Immunol Med Microbiol (2009) 1.01
Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation. Mol Microbiol (2014) 1.00
Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One (2011) 1.00
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99
Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2002) 0.98
Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis (2012) 0.98
The amber theory of Lyme arthritis: initial description and clinical implications. Clin Rheumatol (2012) 0.97
Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines. Infect Immun (2014) 0.97